Crade23: Acute Effect of Functional Crackers on Postprandial Metabolism

Sponsor
University of the Aegean (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05977543
Collaborator
(none)
13
1
3
8
1.6

Study Details

Study Description

Brief Summary

The aim of this interventional study was to investigate the postprandial effect of two types of functional crackers, with 10% grape seed flour or 40% barley flour, enriched with β-glucan, in metabolic biomarkers of healthy participants.

Condition or Disease Intervention/Treatment Phase
  • Other: Functional crackers enriched with grape seed flour
  • Other: Functional crackers with 40% barley flour and enriched with β-glucans
N/A

Detailed Description

A pilot cross-over, controlled, randomized and single-blinded, intervention-clinical trial was carried out, in twelve healthy men and women, aged nineteen to sixty-five years, after random allocation into the control, the grape and the barley interventional groups, received a high-fat and high-carbohydrate meal, containing wheat flour or wheat and 10% grape seed flour or wheat and 40% barley flour, enriched with β-glucan, crackers. Participants consumed the same meals, allocating in cross-over order, with 1 washout week after each trial period. Differences on the metabolism of postprandial serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
On enrolment, all subjects were randomly assigned to the C: F1:F2 group (Control: Functional 1: Functional 2), to the F1: C: F2 group (Functional 1: Control: Functional 2) or to the F2: F1: C group (Functional 2: Functional 1: Control). Subjects in the C: F1:F2 group received the Control meal on the first visit, the Functional meal 1 on the second visit and the Functional meal 2 on the third visit; those in the F1:C:F2 group received the Functional meal 1 on the first visit, the Control meal on the second visit and the Functional meal 2 on the third visit while those in the F2:F1:C group received the Functional meal 2 on the first visit, the meal Functional meal 1 on the second visit and the Control meal on the third visit.On enrolment, all subjects were randomly assigned to the C: F1:F2 group (Control: Functional 1: Functional 2), to the F1: C: F2 group (Functional 1: Control: Functional 2) or to the F2: F1: C group (Functional 2: Functional 1: Control). Subjects in the C: F1:F2 group received the Control meal on the first visit, the Functional meal 1 on the second visit and the Functional meal 2 on the third visit; those in the F1:C:F2 group received the Functional meal 1 on the first visit, the Control meal on the second visit and the Functional meal 2 on the third visit while those in the F2:F1:C group received the Functional meal 2 on the first visit, the meal Functional meal 1 on the second visit and the Control meal on the third visit.
Masking:
Single (Participant)
Masking Description:
Only investigators knew the group in which each participant were enrolled.
Primary Purpose:
Other
Official Title:
The Acute Effect of Functional Crackers, Enriched With Grape Seed Flour or With Barley Flour and β-glucans, on Postprandial Glycemic, Lipemic and Antioxidant Metabolism
Actual Study Start Date :
Feb 15, 2023
Actual Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Oct 15, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control wheat crackers

Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of wheat flour crackers.

Other: Grape seed flour crackers

Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of wheat flour crackers, enriched with 10% grape seed flour crackers.

Other: Functional crackers enriched with grape seed flour
The crackers was enriched with 10% grape seed flour
Other Names:
  • Grape seed flour crackers
  • Other: Barley flour and β-glucan crackers

    Volunteers consumed 80g of white bread, 30g of full fat butter and 55g of 60% wheat flour and 40% barley flour crackers, enriched with β-glucan

    Other: Functional crackers with 40% barley flour and enriched with β-glucans
    The crackers consisted of 60% wheat flour, 40% barley flour and was enriched with β-glucans.
    Other Names:
  • Barley flour crackers
  • Outcome Measures

    Primary Outcome Measures

    1. Glucose [3 hours]

      Glucose concentration changes from baseline at 3hours

    2. Total Antioxidant Capacity [3 hours]

      Total Antioxidant Capacity concentration changes from baseline at 3 hours

    Secondary Outcome Measures

    1. Total cholesterol [3 hours]

      Total cholesterol concentration changes from baseline at 3hours

    2. High Density Lipoprotein cholesterol [3 hours]

      High Density Lipoprotein concentration cholesterol changes from baseline at 3hours

    3. Low Density Lipoprotein cholesterol [3 hours]

      Low Density Lipoprotein cholesterol concentration changes from baseline at 3hours

    4. Triglycerides [3 hours]

      Triglycerides concentration changes from baseline at 3hours

    5. Uric Acid [3 hours]

      Uric Acid concentration changes from baseline at 3hours

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 19-65 years
    Exclusion Criteria:
    • Age over 65 years old

    • History of chronic illness including type I and II diabetes (hemoglobin A1c-HbA1c > 5%)

    • Abnormal Body Mass Index (BMI) (>25 kg/m2)

    • Alcohol overconsumption (>40 g alcohol/day)

    • Abnormal hematological and biochemical profiles (cholesterol > 6.8 mM, triglycerides > 2.8 mM, glucose > 6.11 mM)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of the Aegean Myrina Limnos/Lesvos Greece 81 400

    Sponsors and Collaborators

    • University of the Aegean

    Investigators

    • Study Director: Antonios Koutelidakis, Professor, University of the Aegean

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of the Aegean
    ClinicalTrials.gov Identifier:
    NCT05977543
    Other Study ID Numbers:
    • 12123
    First Posted:
    Aug 4, 2023
    Last Update Posted:
    Aug 8, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of the Aegean

    Study Results

    No Results Posted as of Aug 8, 2023